Exports In 2022, Sweden exported $4.72B in Vaccines, blood, antisera, toxins and cultures, making it the 13th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in Sweden. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Sweden are: United States ($1.18B), Germany ($793M), China ($484M), Austria ($306M), and France ($233M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Sweden between 2021 and 2022 were United States ($629M), China ($410M), and Austria ($230M).
Imports In 2022, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, becoming the 20th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in Sweden. Sweden imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($740M), Germany ($685M), Belgium ($439M), Netherlands ($198M), and Switzerland ($162M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Sweden between 2021 and 2022 were Belgium ($239M), United States ($96.6M), and South Korea ($40M).